iabetes mellitus increases the risk of acute coronary events and is similar to that of people without diabetes who have experienced a myocardial infarction (MI). Left ventricular failure is a major contributor to the excess mortality observed in diabetic MI. This review explores this excess risk and considers strategies for its prevention and treatment.
Haffner SM, Lehto S., Ronnemaa T., Pyorala K., Laakso M.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med1998;339:229-34.
2.
Wild S., Roglic G., Green A., Sicree R., King H.Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care2004;27:1047-53.
3.
Aguilar D., Solomon SD, Kober L. et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation2004 ;110:1572-8.
4.
Mukamal KJ, Nesto RW, Cohen MC et al. Impact of diabetes on longterm survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care2001;24:1422-7.
5.
Franklin K., Goldberg RJ, Spencer F. et al. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med2004;164:1457-63.of insulin-glucose
6.
Malmberg K., Ryden L., Efendic S. et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol1995;26:57-65.
7.
Malmberg K., Yusuf S., Gerstein HC et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation2000;102:1014-19.
8.
Orlander PR, Goff DC, Morrissey M. et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes1994;43:897-902.
9.
Stone PH, Muller JE, Hartwell T. et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol1989;14:49-57.
10.
Melchior T. , Rask-Madsen C., Torp-Pedersen C., Hildebrandt P., Kober L., Jensen G.The impact of heart failure on prognosis of diabetic and non-diabetic patients with myocardial infarction: a 15-year follow-up study. Eur J Heart Fail2001;3:83-90.
11.
Foo K., Sekhri N., Deaner A. et al. Effect of diabetes on serum potassium concentrations in acute coronary syndromes. Heart2003;89:31-5.
12.
Culic V., Eterovic D., Miric D., Silic N.Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors. Am Heart J2002 ;144:1012-17.
13.
Canto JG, Shlipak MG, Rogers WJ et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA2000;283:3223-9.
14.
Airaksinen KESilent coronary artery disease in diabetes - a feature of autonomic neuropathy or accelerated atherosclerosis?Diabetologia2001;44:259-66.
15.
Ottesen MM, Kober L., Jorgensen S., Torp-Pedersen C.Determinants of delay between symptoms and hospital admission in 5978 patients with acute myocardial infarction. The TRACE Study Group. Trandolapril Cardiac Evaluation. Eur Heart J1996;17:429-37.
16.
Sutton MGS , Sharpe N.Left Ventricular Remodeling After Myocardial Infarction:Pathophysiology and Therapy. Circulation2000;101:2981-8.
17.
Pfeffer MA, Braunwald E.Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation1990 ;81:1161-72.
18.
Iwasaka T., Takahashi N., Nakamura S. et al. Residual left ventricular pump function after acute myocardial infarction in NIDDM patients. Diabetes Care1992;15:1522-6.
19.
Solomon SD, St John SM, Lamas GA et al. Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction. Circulation2002;106:1251-5.
20.
Dini FL, Volterrani C., Azzarelli A. et al. Left ventricular size and function in patients with noninsulin-dependent diabetes and postinfarction total or subtotal coronary occlusions. Angiology1998;49:967-73.
21.
Carrabba N., Valenti R., Parodi G., Santoro GM, Antoniucci D.Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction. Circulation2004;110: 1974-9.
22.
Boyer JK, Thanigaraj S., Schechtman KB, Perez JEPrevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol2004;93:870-5.
23.
Zabalgoitia M., Ismaeil MF, Anderson L., Maklady FAPrevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol2001 ;87:320-3.
24.
Fang ZY, Schull-Meade R., Leano R., Mottram PM, Prins JB, Marwick THScreening for heart disease in diabetic subjects. Am Heart J2005;149:349-54.
25.
Di B.V. , Talarico L., Picano E. et al. Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. J Am Coll Cardiol1995;25:1408-15.
26.
Perez JE, McGill JB, Santiago JV et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol1992;19:1154-62.
27.
Granger CB, Califf RM, Young S. et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol1993;21:920-5.
28.
Vinereanu D. , Nicolaides E., Tweddel AC et al. Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond)2003;105:591-9.
29.
Fang ZY, Yuda S., Anderson V., Short L., Case C., Marwick THEchocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol2003;41:611-17.
30.
Kannel WB, Hjortland M., Castelli WPRole of diabetes in congestive heart failure: the Framingham study . Am J Cardiol1974;34:29-34.
31.
Rubler S., Dlugash J., Yuceoglu YZ, Kumral T., Branwood AW, Grishman A.New type of cardiomyopathy associated with diabetic glomerulosclerosis . Am J Cardiol1972;30:595-602.
32.
Hardin NJThe myocardial and vascular pathology of diabetic cardiomyopathy. Coron Artery Dis1996;7:99-108.
33.
Di Carli MF , Bianco-Batlles D., Landa ME et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation1999Aug24;100:813-19.
34.
Foo K., Sekhri N., Knight C. et al. The effect of diabetes on heart rate and other determinants of myocardial oxygen demand in acute coronary syndromes. Diabet Med2004;21:1025-31.
35.
Bell DSHeart failure: the frequent, forgotten, and often fatal complication of diabetes . Diabetes Care2003;26:2433-41.
36.
Oliver MF, Opie LHEffects of glucose and fatty acids on myocardial ischaemia and arrhythmias . Lancet1994;343:155-8.
37.
Williams IL , Noronha B., Zaman AGThe management of acute myocardial infarction in patients with diabetes mellitus. Br J Diabetes Vasc Dis2003;3:319-24.
38.
Pfeffer MA, Moye LA, Braunwald E. et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. JAMA1991 ;266:528-32.
39.
Shotliff K. , Kaushal R., Dove D., Nussey SSWithholding thrombolysis in patients with diabetes mellitus and acute myocardial infarction. Diabet Med1998;15:1028-30.
40.
Younis N., Burnham P., Patwala A., Weston PJ, Vora JPBeta blocker prescribing differences in patients with and without diabetes following a first myocardial infarction. Diabet Med2001;18:159-61.
41.
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet1988;2:349-60.
42.
Goldberg RB , Mellies MJ, Sacks FM et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators . Circulation1998;98:2513-19.
43.
Ingelsson E. , Sundstrom J., Arnlov J., Zethelius B., Lind L.Insulin resistance and risk of congestive heart failure. JAMA2005;294:334-41.
44.
Wison S., Foo K., Cunningham J. et al. Renal function and risk stratification in acute coronary syndromes . Am J Cardiol2003;91:1051-4.
45.
Archbold RA , Balami D., Al-Hajiri A. et al. Haemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J2006;in press.
46.
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet1994;343:311-22.
47.
Farkouh ME, Ramanathan K., Aymong ED et al. An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarction. Clin Cardiol2006;29:204-10.
48.
Fath-Ordoubadi F., Beatt KJGlucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation1997;96:1152-6.
49.
Malmberg K. , Ryden L., Wedel H. et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J2005;26: 650-61.
50.
Nesto RW, Zarich S.Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition. Circulation1998;97:12-15.
51.
Rutherford JD, Pfeffer MA et al. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation1994 ;90:1731-8.
52.
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet2000;355:253-9.
53.
Zuanetti G. , Latini R., Maggioni AP, Franzosi M., Santoro L., Tognoni G.Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation1997;96:4239-45.
